Literature DB >> 6499284

Improved standardization in the quantitative estimation of soluble immune complexes making use of an international reference preparation. Results of a collaborative multicentre study.

U E Nydegger, S E Svehag.   

Abstract

Heat aggregated immunoglobulin G (A-IgG) of restricted size and complement solubilized tetanus toxoid (Te): human anti-Te immune complexes (IC) were sent as coded test samples to eight laboratories for quantitative assessment by different IC assay techniques including C1q solid and fluid phase binding assays, conglutinin binding assay. Raji cell test and particle counting immunoassay. In addition, samples containing the same material at concentrations communicated to the laboratories for the performance of reference curves were included. The investigators were asked to estimate the quantity of A-IgG or Te:aTe in the coded samples by reference to both their own locally produced standards and to the A-IgG and Te:aTe reference preparations of known concentrations. When calculated on the basis of locally prepared standards the range of concentrations found by the various laboratories and tests was 20-260 micrograms/ml for A-IgG (actual concentration 50 micrograms/ml) and 32-1,420 micrograms/ml for Te:aTe complexes (actual concentration 40 micrograms complexed antibody/ml). When read on the international candidate reference A-IgG preparation these ranges were 28-800 micrograms/ml and 35-800 micrograms/ml, respectively. The highest standardization efficiency was obtained when the Te:aTe reference curve was used for quantitation: the range of results obtained for A-IgG and Te:aTe coded samples being as narrow as 7-40 micrograms/ml and 34-68 micrograms/ml, respectively. Thus, when the content of the coded samples was estimated on the basis of the Te:aTe reference curves established in the laboratories a narrow clustering of the results was seen. It is proposed that the Te:aTe preparation, which has been found stable during storage for 2 years, could serve as a useful international reference preparation in the field of IC determination.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6499284      PMCID: PMC1577068     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  7 in total

Review 1.  The biology and detection of immune complexes.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Adv Immunol       Date:  1979       Impact factor: 3.543

2.  Particle counting immunoassay (PACIA). II. Automated determination of circulating immune complexes by inhibition of the agglutinating activity of rheumatoid sera.

Authors:  C L Cambiaso; H Riccomi; C Sindic; P L Masson
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

3.  Routine assay for the detection of immune complexes of known immunoglobulin class using solid phase C1q.

Authors:  F C Hay; L J Nineham; I M Roitt
Journal:  Clin Exp Immunol       Date:  1976-06       Impact factor: 4.330

4.  Solid-phase enzyme immunoassay or radioimmunoassay for the detection of immune complexes based on their recognition by conglutinin: conglutinin-binding test. A comparative study with 125I-labelled Clq binding and Raji-cell RIA tests.

Authors:  P Casali; A Bossus; N A Carpentier; P H Lambert
Journal:  Clin Exp Immunol       Date:  1977-08       Impact factor: 4.330

5.  Detection and quantitation of circulating immune complexes by the C1q-protein A binding assay (C1q-PABA).

Authors:  G Glikmann; S E Svehag
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

6.  The Raji cell radioimmune assay for detecting immune complexes in human sera.

Authors:  A N Theofilopoulos; C B Wilson; F J Dixon
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

7.  Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus.

Authors:  R H Zubler; G Lange; P H Lambert; P A Miescher
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

  7 in total
  5 in total

1.  C3-containing serum immune complexes in patients with systemic lupus erythematosus: correlation to disease activity and comparison with other rheumatic diseases.

Authors:  C Huber; A Rüger; M Herrmann; F Krapf; J R Kalden
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

2.  Extraintestinal manifestations of granulomatous enterocolitis induced in rabbits by long-term submucosal administration of muramyl dipeptide emulsified with Freund's incomplete adjuvant.

Authors:  K Kuroe; Y Haga; O Funakoshi; I Mizuki; K Kanazawa; Y Yoshida
Journal:  J Gastroenterol       Date:  1996-04       Impact factor: 7.527

3.  The collagen-like component of the complement system, C1q, is recognized by 7 S autoantibodies and is functionally impaired in synovial fluids of patients with rheumatoid arthritis.

Authors:  P K Trinder; M J Maeurer; D Brackertz; M Loos
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

4.  C1q-bearing immune complexes detected by a monoclonal antibody to human C1q in rheumatoid arthritis sera and synovial fluids.

Authors:  U Antes; H P Heinz; D Schultz; D Brackertz; M Loos
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

Review 5.  Circulating immune complexes in HIV-infected persons.

Authors:  F E Krapf; M Herrmann; W Leitmann; B Schwartländer; J R Kalden
Journal:  Klin Wochenschr       Date:  1990-03-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.